Analyst consensus rating
InflaRx Analyst Rating: none
Direct answer
InflaRx's consensus rating is none.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.68.
Forecast evidence checked October 17, 2026.
Get free InflaRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.32
- Average price target
- $7.68
- High price target
- $13.66
- Low price target
- $2.93
- Low target gap
- +121.7%
- Target upside
- +481.9%
- High target gap
- +934.7%
- Target range width
- 813%
- Consensus rating
- none
- Analysts
- 9
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for InflaRx?
InflaRx has a verified none consensus. The same dataset has an average price target of $7.68.
How far are InflaRx's low and high targets from the recorded price?
The low target implies +121.7%, while the high target implies +934.7%.
How many analysts are included in InflaRx's consensus?
The verified consensus includes 9 analysts.
How is InflaRx's target upside or downside calculated?
The average target of $7.68 is divided by the recorded price of $1.32, then one is subtracted to produce +481.9%. This does not guarantee a future return.
When was InflaRx's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.